Differential Signaling Pathways in Medulloblastoma: Nano-biomedicine TargetingNon-coding Epigenetics to Improve Current and Future TherapeuticsDaniil Sokolov, Kseniia Denisenko, Emad B. Basalious et al.|Current Pharmaceutical Design|2023Cited by 58
SOX2 and OCT4 mediate radiation and drug resistance in pancreatic tumor organoidsSanjit K. Roy, Hem D. Shukla|Cell Death Discovery|2024Cited by 16